Clinical Trial Update: Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) [Phase 1]

View source ↗

Summary

Completed Phase 1 study evaluating super-selective intraarterial intracranial infusion of bevacizumab (Avastin) for glioblastoma and anaplastic astrocytoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 | Status: COMPLETED